EMCDDA Scientific Committee

Members

Prof. Salme Ahlström, National research and development centre for welfare and
health, Helsinki, Finland

Dr Robert Wennig, Laboratoire National de la Santé, Centre Universitaire du
Luxembourg, Luxembourg

Dr Desmond Corrigan, School of pharmacy, Trinity College, Dublin, Ireland

Dr Sheila Bird, MRC Biostatistics unit, Institute of public health, University Forvie Site,
Cambridge, UK

Dr João Goulão, Drug addiction prevention and treatment service, Ministry of health,
Lisbon, Portugal

Dr Katerina Matsa, Psychiatric unit 18 ANO, Psychiatric hospital of Athens, Athens,
Greece

Dr Björn Hibell, Centralförbundet för alkohol-och narkotikaupplysning (CAN),
Stockholm, Sweden

Prof. Dr Henk Garretsen, Faculty of social and behavioural sciences, Tilburg
University, Tilburg, Netherlands

Prof. Dr Joris Casselman, Centre for forensic mental health, Catholic University of
Leuven, Belgium

Dr Carlo Perucci, Department of epidemiology, Local Health Authority, Rome, Italy

Dr Anne-Marie Sindballe, National board of health, Copenhagen, Denmark

Dr Jean-Pol Tassin, Inserm U 114 Unit, Neuropharmacology, Research Inserm,
Collège de France Paris, France

Dr Christina Poethko-Müller, Federal institute for drugs and medical devices, Bonn,
Germany

Dr Wolfgang Werdenich, Special detention centre for the treatment of addicted
offenders, Office of Justice, Vienna, Austria

Dr Astrid Skretting, National institute for alcohol and drug research, Oslo, Norway

Representatives of the European Commission, Europol and the European Agency for
the Evaluation of Medicinal Products (EMEA)

Mr Matthias Halldorsson, European Commission (SANCO DG), Luxembourg

Mr Juan Crespo, European Commission (ENTR DG), Brussels, Belgium

Dr Juhana Idänpään-Heikkilä, Sector for pre-authorisation for the evaluation of
medicines for human use, EMEA, London, UK

Mr Richard Weijenburg, Europol, the Hague, the Netherlands

Additional experts from the EU Member States

Dr Claude Barjhoux, Centre d’evaluation et d’information sur la
pharmacodépendance (CEIP), Grenoble, France

Mr Carlo Bertorello, CNR, National council of research, Pisa, Italy

Dr Wim Best, Inspectorate of health care, public health supervisory service of the
Netherlands, the Hague, the Netherlands

Dr Robin Braithwaite, City Hospital NHS Trust, Birmingham, UK

Ms Milagros Diego, Government delegation for the national plan on drugs, Madrid,
Spain

Dr Conny Eklund, Medical products agency, Uppsala, Sweden

Dr Fernanda Feijão, Instituto português da droga e da toxicodependência, Lisbon,
Portugal

Prof. Álvaro Lopes, Forensic science laboratory of the criminal police, Lisbon, Portugal

Dr Robert Lousberg, Inspectorate of health care, public health supervisory service of
the Netherlands, the Hague, the Netherlands

Dr Heini Kainulainen, National research institute of legal policy, department of
criminology, Helsinki, Finland

Dr Sean McDermott, Forensic science laboratory, An Garda Síochana, Dublin, Ireland

Dr Henrik Rindom, Psychiatric department, Hvidovre Hospital, Brøndby, Denmark

Prof. Dr Hans Rommelspacher, Free University of Berlin, Berlin, Germany

Dr Hara Spiliopoulou, department of forensic medicine and toxicology, medical
school, University of Athens, Athens, Greece

Dr Crista van Haeren, Institut National de Criminologie et Criminalistique, Brussels,
Belgium